Production of 21-hydroxy-20-methyl-pregna-1,4-dien-3-one by modifying multiple genes in Mycolicibacterium
Applied Microbiology and Biotechnology · 2023
DOI: 10.1007/s00253-023-12399-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Microbiology and Biotechnology, 2023. Verfasst von Chenyang Yuan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Lab of Biorefinery, Shanghai Advanced Research Institute, Chinese Academy of Sciences, No. 99 Haike Road, Pudong, Shanghai, 201210, China. Hauptthemen laut MEDLINE: Mycobacterium, Phytosterols. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: National Key R&D Program of China.
Abstract (Originalsprache)
C22 steroid drug intermediates are suitable for corticosteroids synthesis, and the production of C22 steroids is unsatisfactory due to the intricate steroid metabolism. Among the C22 steroids, 21-hydroxy-20-methyl-pregna-1,4-dien-3-one (1,4-HP) could be used for Δ1-steroid drug synthesis, such as prednisolone. Nevertheless, the production of 1,4-HP remains unsatisfactory. In this study, an ideal 1,4-HP producing strain was constructed. By the knockout of 3-ketosteroid-9-hydroxylase (KshA) genes and 17β-hydroxysteroid dehydrogenase (Hsd4A) gene, the steroid nucleus degradation and the accumulation of C19 steroids in Mycolicibacterium neoaurum were blocked. The mutant strain could transform phytosterols into 1,4-HP as the main product and 21-hydroxy-20-methyl-pregna-4-ene-3-one as a by-product. Subsequently, the purity of 1,4-HP improved to 95.2% by the enhancement of 3-ketosteroid-Δ1-dehydrogenase (KSTD) activity, and the production of 1,4-HP was improved by overexpressing NADH oxidase (NOX) and catalase (KATE) genes. Consequently, the yield of 1,4-HP achieved 10.5 g/L. The molar yield and the purity of 1,4-HP were optimal so far, and the production of 1,4-HP provides a new intermediate for the pharmaceutical steroid industry. KEY POINTS: • A third 3-ketosteroid-9-hydroxylase was identified in Mycolicibacterium neoaurum. • An 1,4-HP producer was constructed by KshA and Hsd4A deficiency. • The production of 1,4-HP was improved by KSTD, NOX, and KATE overexpression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Lab of Biorefinery, Shanghai Advanced Research Institute, Chinese Academy of Sciences, No. 99 Haike Road, Pudong, Shanghai, 201210, China.
- School of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, China.
- University of Chinese Academy of Sciences, Beijing, 100049, China.
- Department of Biology, Waterville, ME, 04901, USA.
- Lab of Biorefinery, Shanghai Advanced Research Institute, Chinese Academy of Sciences, No. 99 Haike Road, Pudong, Shanghai, 201210, China. zhangbg@sari.ac.cn.
- University of Chinese Academy of Sciences, Beijing, 100049, China. zhangbg@sari.ac.cn.
Förderung
- National Key R&D Program of China
Zitieren
APA
Yuan, C., Ma, Z., Li, Y., Zhang, J., Liu, X., Han, S., Du, G., Shi, J., Sun, J., & Zhang, B. (2023). Production of 21-hydroxy-20-methyl-pregna-1,4-dien-3-one by modifying multiple genes in Mycolicibacterium. Applied Microbiology and Biotechnology. https://doi.org/10.1007/s00253-023-12399-2
Vancouver
Yuan C, Ma Z, Li Y, Zhang J, Liu X, Han S, et al. Production of 21-hydroxy-20-methyl-pregna-1,4-dien-3-one by modifying multiple genes in Mycolicibacterium. Applied Microbiology and Biotechnology. 2023. doi:10.1007/s00253-023-12399-2
BibTeX
@article{Yuan2023,
author = {Yuan, Chenyang and Ma, Zhiguo and Li, Yixin and Zhang, Jingxian and Liu, Xiangcen and Han, Suwan and Du, Guilin and Shi, Jiping and Sun, Junsong and Zhang, Baoguo},
title = {Production of 21-hydroxy-20-methyl-pregna-1,4-dien-3-one by modifying multiple genes in Mycolicibacterium},
journal = {Applied Microbiology and Biotechnology},
year = {2023},
doi = {10.1007/s00253-023-12399-2}
}
EUVIMED